Results 211 to 220 of about 20,276 (258)

Potential Compounds as Inhibitors of Staphylococcal Virulence Factors Involved in the Development of Thrombosis. [PDF]

Toxins (Basel)
Lichota A, Gwozdzinski K, Sienkiewicz M.
europepmc   +1 more source

Contrasting the gut microbiome in Colombian patients with diarrhea: a comparative metagenomic study in hospitalization and emergency room services. [PDF]

Gut Pathog
Vega L, Birchenall-Jiménez CI, Aponte A, Durán D, López C, Moreno-Matson MC, Perilla C, Pinilla D, Rodríguez-Leguizamón G, Sánchez E, Santana A, Herrera G, Ramírez JD, Muñoz M.   +13 more
europepmc   +1 more source

Regulatory considerations for developing phage therapy medicinal products for the treatment of antimicrobial resistant bacterial infections. [PDF]

Front Pharmacol
Fukaya-Shiba A, Ogata A, Kuribayashi R, Sakurai A, Suzuki K, Takadama S, Nishimura J, Uchiyama J, Ohge H, Takeuchi T, Tamaki H, Matsumoto T, Kiga K, Iwano H.   +13 more
europepmc   +1 more source

Richard Pfeiffer 1858-1945 [PDF]

, 2018
von Graevenitz, A.
core  

Prevalence of exotoxin and type III secretion system genes in multidrug-resistant Pseudomonas aeruginosa isolates from patients with burn injuries in Southern Iran. [PDF]

BMC Infect Dis
Dejman SP, Emami A, Pirbonyeh N, Radfar A, Javanmardi F, Moattari A.   +5 more
europepmc   +1 more source

Production of the broad host range Salmonella phage PVP-SE1 with safety concerns [PDF]

, 2010
Azeredo, Joana, Ferreira, E. C., Santos, Sílvio Roberto Branco   +2 more
core  

Detection of virulence factors in opportunistic bacteria: advances, challenges, and practical implementation. [PDF]

Front Microbiol
Chebotar I, Azizov I, Edelstein M, Kozlov R.   +3 more
europepmc   +1 more source